MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.540
+0.050 (3.36%)
Sep 5, 2025, 4:00 PM - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $50.81 million as of September 5, 2025. Its market cap has decreased by -23.28% in one year.
Market Cap
50.81M
Enterprise Value
40.67M
1-Year Change
-23.28%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has decreased from $51.10M to $50.81M, a decrease of -0.57%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 50.81M | -1.90% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |